{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:00Z","timestamp":1790337780029,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY23C100001"],"award-info":[{"award-number":["LY23C100001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["B2022202029"],"award-info":[{"award-number":["B2022202029"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103550","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:54:56Z","timestamp":1786492496000},"page":"103550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biohybrid Salmonella typhimurium for synergistic chemoimmunotherapy via localized chemotherapy and in situ PD-L1 blockade"],"prefix":"10.1016","volume":"40","author":[{"given":"Longxue","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hancheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-1818","authenticated-orcid":false,"given":"Xingang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2641-0588","authenticated-orcid":false,"given":"Xiuli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7378","key":"10.1016\/j.mtbio.2026.103550_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103550_bib2","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103550_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103550_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","article-title":"Clinical challenges of immune checkpoint inhibitors","volume":"38","author":"de Miguel","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Brit J Cancer"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103550_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103550_bib8","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103550_bib9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41416-023-02181-6","article-title":"Immune checkpoint inhibitor combinations-current and emerging strategies","volume":"128","author":"Walsh","year":"2023","journal-title":"Brit J Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103550_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103550_bib12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/2159-8290.CD-20-1312","article-title":"Paradigms on immunotherapy combinations with chemotherapy","volume":"11","author":"Salas-Benito","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40820-020-00482-6","article-title":"A review on nano-based drug delivery system for cancer chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.mtbio.2026.103550_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119513","article-title":"Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer","volume":"585","author":"Nie","year":"2020","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13036-019-0189-9","article-title":"Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy","volume":"13","author":"He","year":"2019","journal-title":"J. Biol. Eng."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103550_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108557","article-title":"Harnessing bacteria for tumor therapy: current advances and challenges","volume":"35","author":"Guo","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.mtbio.2026.103550_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1675682","article-title":"Precision bacterial immunotherapy: an integrated mechanistic taxonomy and translational roadmap against antimicrobial resistance","volume":"16","author":"Al-Azzani","year":"2025","journal-title":"Front. Immunol."},{"issue":"31","key":"10.1016\/j.mtbio.2026.103550_bib18","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0701959104","article-title":"Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth","volume":"104","author":"Loeffler","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103550_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.molmed.2012.05.006","article-title":"Bioengineered microbes in disease therapy","volume":"18","author":"Paton","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103550_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103550_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103550_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108202","article-title":"Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications","volume":"67","author":"Yu","year":"2023","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-023-01440-5","article-title":"Applications of synthetic biology in medical and pharmaceutical fields","volume":"8","author":"Yan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103550_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.trecan.2020.11.004","article-title":"Tweak to treat: reprograming bacteria for cancer treatment","volume":"7","author":"Sieow","year":"2021","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103550_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acssynbio.1c00452","article-title":"Precise thermal regulation of engineered bacteria secretion for breast cancer treatment in vivo","volume":"11","author":"Li","year":"2022","journal-title":"ACS Synth. Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib26","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1038\/s41467-022-31932-x","article-title":"Spatiotemporal control of engineered bacteria to express interferon-gamma by focused ultrasound for tumor immunotherapy","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib27","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103550_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat. Med."},{"issue":"7614","key":"10.1016\/j.mtbio.2026.103550_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41522-024-00479-8","article-title":"Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer","volume":"10","author":"Zhou","year":"2024","journal-title":"npj Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103550_bib32","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1021\/acs.nanolett.2c03608","article-title":"Interference of glucose bioavailability of tumor by engineered biohybrids for potentiating targeting and uptake of antitumor nanodrugs","volume":"22","author":"Wang","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103550_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.actbio.2023.07.051","article-title":"Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression","volume":"169","author":"Wu","year":"2023","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103550_bib34","article-title":"Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy","volume":"5","author":"Yang","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103550_bib35","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1021\/acs.nanolett.7b05323","article-title":"Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-alpha expression via oral administration","volume":"18","author":"Fan","year":"2018","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103550_bib36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/acsnano.3c05714","article-title":"Surface mineralization of engineered bacterial outer membrane vesicles to enhance tumor photothermal\/immunotherapy","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"issue":"43","key":"10.1016\/j.mtbio.2026.103550_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310158","article-title":"Engineered bacteria labeled with Iridium(III) photosensitizers for enhanced photodynamic immunotherapy of solid tumors","volume":"62","author":"Lin","year":"2023","journal-title":"Angew. Chem."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103550_bib38","article-title":"Upconversion dual-photosensitizer\u2013expressing bacteria for near-infrared monochromatically excitable synergistic phototherapy","volume":"10","author":"Chen","year":"2024"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103550_bib39","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat. Commun."},{"issue":"100","key":"10.1016\/j.mtbio.2026.103550_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn9879","article-title":"Programmable bacteria synergize with PD-1 blockade to overcome cancer cell\u2013intrinsic immune resistance mechanisms","volume":"9","author":"Li","year":"2024","journal-title":"Sci. Immunol."},{"issue":"530","key":"10.1016\/j.mtbio.2026.103550_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103550_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc9436","article-title":"Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity","volume":"9","author":"Savage","year":"2023","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103550_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt7298","article-title":"Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy","volume":"11","author":"Xie","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103550_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102442","article-title":"Dynamic polyphenol nanoparticles boost cuproptosis-driven metalloimmunotherapy of breast cancer","volume":"58","author":"Zhang","year":"2024","journal-title":"Nano Today"},{"issue":"26","key":"10.1016\/j.mtbio.2026.103550_bib45","doi-asserted-by":"crossref","first-page":"22412","DOI":"10.1021\/jacs.5c00124","article-title":"Engineering of sono-activatable immunogels for immunometabolism disorder normalization therapy of breast cancer","volume":"147","author":"Guo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"23","key":"10.1016\/j.mtbio.2026.103550_bib46","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1021\/acs.chemrev.5c00549","article-title":"Reversible chemistry for cancer therapy and diagnosis","volume":"125","author":"Xu","year":"2025","journal-title":"Chem. Rev."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:27:15Z","timestamp":1790335635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426007957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S2590006426007957"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103550","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biohybrid Salmonella typhimurium for synergistic chemoimmunotherapy via localized chemotherapy and in situ PD-L1 blockade","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103550"}}